Mirum Pharmaceuticals, Inc.

NASDAQ
MIRM
Stock
Yield per half year: -5.07%
Dividend yield: 0%
Sector: Healthcare

Mirum Pharmaceuticals, Inc.

56.0056.0052.0052.0048.0048.0044.0044.0040.0040.0036.0036.00Aug '24Aug '24Sep '24Sep '24Oct '24Oct '24Nov '24Nov '24Dec '24Dec '2420252025Feb '25Feb '25Mar '25Mar '25Apr '25Apr '25May '25May '25Jun '25Jun '25

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
0/10
0 64.15 -100% -5.92 -100%
P/S 5.83 32.77 -82.2%
P/BV 8.71 18.96 -54.08%
P/FCF 101.48 -11.83 -957.67%
Ev/Ebitda -42.07 274.79 -115.31%
Ev/S 6.12 21.64 -71.74%
Ev/FCF 220.78 -15.09 -1563.05%
E/P -0.0929 0.0188 -593.04%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
-14.54 -11 32.12% -119.8 -87.87%
ROE -37.08 14.17 -361.69%
ROA -13.35 1.18 -1229.66%
ROIC 0 7.63 -100%
ROS -26.1 -22.82 14.39%
ROCE -32.18 1.26 -2663.54%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-6.49 1.28 -608.51% -3.06 +112.14%
Nеt Debt/Ebitda -1.95 -10.2 -80.93%
Debt/Ratio 0.4737 0.1978 139.52%
Debt/Equity 1.97 2.77 -28.67%
Debt/Net Income -3.61 2.46 -246.66%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 0.527 -100% 0 0%
Number of years of dividend growth 0 0.9211 -100%
DSI 0 0.2387 -100%
Average dividend growth 0 1.14 -100%
Average percentage for 5 years 0 0.5511 -100%
Average percentage for payments 0 64.78 -100%
Difference from average difference in sector -0.527

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
10/10
2962.62 68.41 4230.68%
Growth impulse Ebitda in 5 years -52.42 30.09 -274.21%
Growth impulse Net Income in 5 years -14.84 -6.56 126.22%
Growth impulse FCF in 5 years -110.45 27.51 -501.49%
Growth impulse EPS in 5 years -54.75 22.93 -338.77%
IP Score
2.66/10

Similar companies

Illumina

Incyte

Amarin

ImmunoGen

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription